Daxor Corporation (DXR) Financials
DXR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 34.9 million | 858758 |
| 2023-06-30 | 30.4 million | ? |
| 2023-03-31 | 30.4 million | ? |
| 2022-12-31 | 30.3 million | 1.3 million |
DXR Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -3.8 million | ? |
| 2023-06-30 | -2.6 million | 162137 |
| 2023-03-31 | -1.4 million | 162137 |
| 2022-12-31 | -1.9 million | 255576 |
DXR Net Income
Graph available only for supporters. Become a supporter to see it.
| Date | Net Income |
|---|---|
| 2023-12-31 | 3.3 million |
| 2023-06-30 | -3.0 million |
| 2023-03-31 | -1.5 million |
| 2022-12-31 | 7.0 million |
DXR Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-06-30 | - | - | - |
| 2023-03-31 | - | - | - |
| 2022-12-31 | - | - | - |
DXR Shares Outstanding
DXR Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-06-30 | - | - | 218024 | - |
| 2023-03-31 | - | - | 218024 | - |
| 2022-12-31 | - | - | 360721 | - |
DXR Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 36.4 million | -4636 |
| 2023-06-30 | -1.8 million | 439316 |
| 2023-03-31 | 40487 | - |
| 2022-12-31 | -324140 | 726183 |
DXR
Price: $9.80
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.14 USD
P/E Ratio: -102.63
Exchange: NCM
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 5100
Market Capitalization: 47.1 million
Average Dividend Frequency: 2